- Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Wong, M.L., Webster, E.L., Spokes, H., Phu, P., Ehrhart-Bornstein, M., Bornstein, S., Park, C.S., Rice, K.C., Chrousos, G.P., Licinio, J., Gold, P.W. Life Sci. (1999)